(0.05%) 5 520.00 points
(0.10%) 39 884 points
(0.16%) 19 782 points
(-0.06%) $81.58
(0.60%) $2.83
(-0.26%) $2 338.20
(0.10%) $29.56
(0.46%) $1 006.40
(0.07%) $0.932
(-0.09%) $10.52
(0.00%) $0.788
(-0.85%) $87.25
8.93% $ 19.63
Live Chart Being Loaded With Signals
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 216 623 |
Średni wolumen | 174 970 |
Kapitalizacja rynkowa | 1.77B |
EPS | $-1.140 ( Q1 | 2024-05-08 ) |
Następna data zysków | ( $-0.590 ) 2024-08-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-7.27 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0800 (0.41%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-20 | Davidson Michael H. | Buy | 5 000 | Ordinary Shares |
2024-04-25 | Jones William A Jr | Sell | 815 598 | Option (right to buy) |
2024-04-25 | Jones William A Jr | Sell | 130 000 | Option (right to buy) |
2024-04-01 | Audet Juliette Berangere | Buy | 250 000 | Option (right to buy) |
2024-03-26 | Topper James N | Buy | 8 429 | Ordinary Shares |
INSIDER POWER |
---|
-58.80 |
Last 41 transactions |
Buy: 2 694 306 | Sell: 10 558 317 |
Wolumen Korelacja
NewAmsterdam Pharma Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
NewAmsterdam Pharma Korelacja - Waluta/Towar
NewAmsterdam Pharma Finanse
Annual | 2023 |
Przychody: | $14.09M |
Zysk brutto: | $14.05M (99.68 %) |
EPS: | $-2.15 |
FY | 2023 |
Przychody: | $14.09M |
Zysk brutto: | $14.05M (99.68 %) |
EPS: | $-2.15 |
FY | 2022 |
Przychody: | $97.50M |
Zysk brutto: | $97.43M (99.93 %) |
EPS: | $-7.85 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
NewAmsterdam Pharma
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej